4//SEC Filing
Williams David Michael 4
Accession 0001127602-23-004855
CIK 0000310158other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 4:17 PM ET
Size
8.5 KB
Accession
0001127602-23-004855
Insider Transaction Report
Form 4
Williams David Michael
EVP,Chief Info&Digital Officer
Transactions
- Exercise/Conversion
Common Stock
2023-02-10$106.72/sh+1,205$128,598→ 12,504.892 total - Tax Payment
Common Stock
2023-02-10$106.72/sh−413$44,075→ 12,091.892 total - Exercise/Conversion
Restricted Stock Unit
2023-02-10−1,205→ 0 totalFrom: 2021-02-10Exp: 2023-02-10→ Common Stock (1,205 underlying)
Footnotes (3)
- [F1]Holdings include shares acquired in dividend reinvestment transactions.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F3]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 2/10/2021, 2/10/2022 and 2/10/2023.
Documents
Issuer
Merck & Co., Inc.
CIK 0000310158
Entity typeother
Related Parties
1- filerCIK 0001820958
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 4:17 PM ET
- Size
- 8.5 KB